세계의 2D 세포 배양 시장 보고서(2025년)
2D Cell Culture Global Market Report 2025
상품코드 : 1877482
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,707,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,694,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,682,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

세계의 2D 세포 배양 시장 규모는 최근 급속히 확대되고 있습니다. 2024년 48억 1,000만 달러에서 2025년에는 53억 달러로 확대되고, CAGR 10.1%로 성장이 전망되고 있습니다. 과거의 성장은 학술 협력 증가, 독성학 연구에서 2D 세포 배양의 이용 확대, 의약품 아웃소싱의 확대, 세포 생물학 교육에 대한 관심 증가, 그리고 비용 효율적인 시험 모델에 대한 수요 증가에 기인한다고 생각됩니다.

2D 세포 배양 시장 규모는 향후 수년간 강력한 성장이 예상되고 있습니다. 2029년까지 77억 달러에 달하고 CAGR은 9.8%가 될 전망입니다. 예측 기간 동안 성장 요인으로는 고처리량 스크리닝의 필요성 증가, 세포 기반 백신 수요 증가, 바이오테크놀러지 기반 스타트업 기업 증가, 생물학적 제제 개발에 대한 주목 증가, 감염증 연구에서 2D 세포 배양의 이용 확대 등을 들 수 있습니다. 예측 기간의 주요 동향으로는 랩 온 칩 플랫폼의 등장, 자동화 시스템과의 통합, 합성 생체 재료의 개발, 나노기술 응용 기술의 진보, 세포 배양 공정에서의 데이터 분석의 응용 확대 등을 들 수 있습니다.

맞춤형 의료에 대한 수요 증가는 앞으로 수년간 2D 세포 배양 시장의 확대를 이끌 것으로 예측됩니다. 맞춤형 의료는 획일적인 치료법을 적용하는 것이 아니라, 개인의 유전자 프로파일, 생활 습관, 환경에 근거해 치료 및 예방 전략을 커스터마이즈하는 의료 접근입니다. 치료 성과의 향상으로 효과가 높고 부작용이 적은 표적 요법을 제공할 수 있기 때문에 맞춤형 의료에 대한 관심이 높아지고 있습니다. 이 접근법은 회복을 가속화하고 환자의 삶의 질을 향상시킵니다. 맞춤형 의료의 필요성이 높아짐으로써, 연구자가 환자 고유의 세포를 배양 및 분석하고, 개별 약제 반응의 연구나 커스터마이즈된 치료 계획의 작성을 가능하게 하는 2D 세포 배양 수요도 증가하고 있습니다. 예를 들어, 2024년 2월 미국 비영리 단체 '맞춤형 의료연합'이 발표한 바에 따르면, 2023년 FDA가 승인한 희소질환용 신규맞춤형 치료는 16건에 이르러 2022년의 6건에서 증가했습니다. 이와 같이 맞춤형 의료에 대한 수요 증가가 2D 세포 배양 시장의 성장에 기여하고 있는 것입니다.

2D 세포 배양 시장의 주요 기업은 세포 부착성의 향상, 자연 조직 환경의 재현, 실험의 일관성 향상을 목적으로 2D 기판용 박막 하이드로겔 코팅 등의 첨단 생체 재료의 개발에 주력하고 있습니다. 2D 기재용 박막 하이드로겔 코팅은 생체 모방적이고 세포 친화성이 있는 환경을 제공하는 특수 표면층으로 2D 배양에서 세포 접착, 증식, 기능성을 향상시킵니다. 예를 들어 2025년 9월 미국 바이오테크놀러지 기업인 TheWell Bioscience Inc.는 혁신적인 이종 유래 성분이 없는 생체모방 하이드로겔 시스템을 발표했습니다. 이 플랫폼은 2D 및 3D 신경 세포 배양뿐만 아니라 생체 내 응용을 위한 주입 가능한 전달을 지원하도록 설계되었습니다. 자연적인 세포 환경을 충실히 재현함으로써 신경 재생 연구를 촉진하는 것을 목적으로 정밀의료, 세포 치료, 바이오 제조의 진보도 지원합니다. 전반적으로, 이 혁신은 효과적인 세포 기반 요법의 개발에 큰 진보를 보여줍니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

JHS
영문 목차

영문목차

2D cell culture is a laboratory method used to grow cells on flat, rigid surfaces such as glass or plastic, allowing the formation of a single-layered structure. It provides a controlled setting for studying cell behavior, biological mechanisms, and drug responses. This technique remains widely used due to its simplicity, cost efficiency, and reproducibility, making it a standard method in research and drug development.

The primary types of 2D cell cultures include skin cells, lung cells, brain cells, kidney cells, liver cells, breast cells, and others. Skin cells refer to in vitro cultured cells used for research, drug testing, and disease modeling in dermatology and related fields. The technique utilizes various technologies, including 2D cell culture platforms, microfluidics technology, automated cell culture systems, incubation and analysis systems, and culture monitoring and control systems. The major application areas include pharmaceuticals, stem cell research, bioproduction, food applications, bioenergy, environmental testing and toxicology, and agriculture. The main end users include pharmaceutical companies, biotechnology companies, contract research organizations, and academic research institutes.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

The 2D cell culture market research report is one of a series of new reports from The Business Research Company that provides 2D cell culture market statistics, including the 2D cell culture industry global market size, regional shares, competitors with the 2D cell culture market share, detailed 2D cell culture market segments, market trends, and opportunities, and any further data you may need to thrive in the 2D cell culture industry. This 2D cell culture market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The 2D cell culture market size has grown rapidly in recent years. It will grow from $4.81 billion in 2024 to $5.30 billion in 2025 at a compound annual growth rate (CAGR) of 10.1%. The growth during the historic period can be attributed to the rise in academic collaborations, the increasing use of 2D cell cultures in toxicology studies, the expansion of pharmaceutical outsourcing, the growing interest in cell biology education, and the rising demand for cost-effective testing models.

The 2D cell culture market size is expected to see strong growth in the next few years. It will grow to $7.70 billion in 2029 at a compound annual growth rate (CAGR) of 9.8%. The growth during the forecast period can be attributed to the increasing need for high-throughput screening, the rising demand for cell-based vaccines, the expansion of biotechnology startups, the growing focus on biologics development, and the increasing use of 2D cell cultures in infectious disease research. Key trends in the forecast period include the emergence of lab-on-a-chip platforms, integration with automated systems, development of synthetic biomaterials, advancements in nanotechnology applications, and the growing application of data analytics in cell culture processes.

The growing demand for personalized medicine is expected to drive the expansion of the 2D cell culture market in the coming years. Personalized medicine is a healthcare approach that customizes treatment and prevention strategies based on an individual's genetic profile, lifestyle, and environment, instead of applying a universal treatment method. The increasing interest in personalized medicine is fueled by improved treatment outcomes, as it offers targeted therapies that are more effective and have fewer adverse effects. This approach enables faster recovery and enhances patients' quality of life. The rising need for personalized medicine boosts the demand for 2D cell culture, as it allows researchers to cultivate and analyze patient-specific cells, facilitating the study of individual drug responses and the creation of customized treatment plans. For example, in February 2024, the Personalized Medicine Coalition, a US-based non-profit organization, reported that the FDA approved 16 new personalized treatments for patients with rare diseases in 2023, compared to six in 2022. Hence, the growing demand for personalized medicine is contributing to the growth of the 2D cell culture market.

Leading companies in the 2D cell culture market are concentrating on the development of advanced biomaterials, such as thin hydrogel coatings for 2D substrates, to enhance cell attachment, replicate natural tissue environments, and increase experimental consistency. Thin hydrogel coatings for 2D substrates are specialized surface layers that provide a biomimetic, cell-compatible setting to improve cell adhesion, proliferation, and functionality in 2D cultures. For example, in September 2025, TheWell Bioscience Inc., a US-based biotechnology company, launched an innovative xeno-free biomimetic hydrogel system. This platform is designed to support both 2D and 3D neuronal cell cultures, as well as injectable delivery for in vivo applications. It aims to promote neuroregenerative research by closely replicating the natural cellular environment and also supports advancements in precision medicine, cell therapy, and biomanufacturing. Overall, this innovation marks a major advancement in the development of effective cell-based therapies.

In April 2023, AnaBios Corporation, a US-based provider of cells derived from organs such as the brain, liver, kidney, eye, and lung, including specialized endothelial cells, acquired Cell Systems for an undisclosed amount. This acquisition enables AnaBios to offer human tissue samples, primary human cells, and human-focused ex vivo services for research in drug discovery and safety evaluation. Cell Systems is a US-based company that supplies products for cell culture, including 2D cell culture.

Major players in the 2d cell culture market are Tecan Group Ltd., Roche Holding AG, Thermo Fisher Scientific Inc., Takara Bio Inc., Danaher Corporation, Merck KGaA, GE Healthcare, Corning Incorporated, Becton Dickinson and Company (BD), Lonza Group AG, Agilent Technologies Inc., Sartorius AG, PerkinElmer Inc., Bio-Rad Laboratories Inc., Eppendorf AG, Bio-Techne Corporation, STEMCELL Technologies Inc., Greiner Bio-One International AG, Promega Corporation, BICO Group AB, Cedarlane Laboratories Ltd., Creative Bioarray Inc., PromoCell GmbH, Biolamina AB, HiMedia Laboratories Pvt. Ltd., 3H Biomedical AB, Cell Microsystems Inc., and AlveoliX AG.

North America was the largest region in the 2D cell culture market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in 2D cell culture report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the 2D cell culture market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The 2D cell culture market consists of revenues earned by entities by providing services such as cell line development, cell banking, assay development, and cytotoxicity testing. The market value includes the value of related goods sold by the service provider or included within the service offering. The 2D cell culture market also includes sales of culture media, petri dishes, flasks, and multiwall plates. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

2D Cell Culture Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on 2d cell culture market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for 2d cell culture ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The 2d cell culture market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. 2D Cell Culture Market Characteristics

3. 2D Cell Culture Market Trends And Strategies

4. 2D Cell Culture Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global 2D Cell Culture Growth Analysis And Strategic Analysis Framework

6. 2D Cell Culture Market Segmentation

7. 2D Cell Culture Market Regional And Country Analysis

8. Asia-Pacific 2D Cell Culture Market

9. China 2D Cell Culture Market

10. India 2D Cell Culture Market

11. Japan 2D Cell Culture Market

12. Australia 2D Cell Culture Market

13. Indonesia 2D Cell Culture Market

14. South Korea 2D Cell Culture Market

15. Western Europe 2D Cell Culture Market

16. UK 2D Cell Culture Market

17. Germany 2D Cell Culture Market

18. France 2D Cell Culture Market

19. Italy 2D Cell Culture Market

20. Spain 2D Cell Culture Market

21. Eastern Europe 2D Cell Culture Market

22. Russia 2D Cell Culture Market

23. North America 2D Cell Culture Market

24. USA 2D Cell Culture Market

25. Canada 2D Cell Culture Market

26. South America 2D Cell Culture Market

27. Brazil 2D Cell Culture Market

28. Middle East 2D Cell Culture Market

29. Africa 2D Cell Culture Market

30. 2D Cell Culture Market Competitive Landscape And Company Profiles

31. 2D Cell Culture Market Other Major And Innovative Companies

32. Global 2D Cell Culture Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The 2D Cell Culture Market

34. Recent Developments In The 2D Cell Culture Market

35. 2D Cell Culture Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기